Shandong Sanyuan BiotechnologyLtd Future Growth
Future criteria checks 5/6
Shandong Sanyuan BiotechnologyLtd is forecast to grow earnings and revenue by 36.6% and 20.2% per annum respectively while EPS is expected to grow by 37.4% per annum.
Key information
36.6%
Earnings growth rate
37.4%
EPS growth rate
| Food earnings growth | 21.7% |
| Revenue growth rate | 20.2% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 02 May 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 881 | 162 | N/A | 224 | 1 |
| 12/31/2024 | 770 | 125 | N/A | 196 | 1 |
| 9/30/2024 | 663 | 98 | -100 | 42 | N/A |
| 6/30/2024 | 641 | 77 | -45 | 80 | N/A |
| 3/31/2024 | 575 | 75 | -46 | 77 | N/A |
| 12/31/2023 | 500 | 59 | -66 | 57 | N/A |
| 9/30/2023 | 463 | 54 | -136 | 16 | N/A |
| 6/30/2023 | 453 | 78 | -99 | 52 | N/A |
| 3/31/2023 | 519 | 109 | -81 | 66 | N/A |
| 1/1/2023 | 675 | 164 | -158 | 84 | N/A |
| 9/30/2022 | 933 | 246 | -79 | 212 | N/A |
| 6/30/2022 | 1,346 | 412 | -24 | 401 | N/A |
| 3/31/2022 | 1,684 | 529 | 11 | 533 | N/A |
| 1/1/2022 | 1,675 | 535 | 208 | 642 | N/A |
| 9/30/2021 | 1,527 | 501 | N/A | N/A | N/A |
| 6/30/2021 | 1,218 | 366 | 54 | 349 | N/A |
| 3/31/2021 | 905 | 262 | N/A | N/A | N/A |
| 12/31/2020 | 783 | 233 | 66 | 217 | N/A |
| 9/30/2020 | 709 | 208 | 84 | 223 | N/A |
| 6/30/2020 | 635 | 183 | 102 | 228 | N/A |
| 3/31/2020 | 522 | 145 | N/A | N/A | N/A |
| 12/31/2019 | 477 | 136 | 8 | 149 | N/A |
| 9/30/2019 | 439 | 125 | 19 | 134 | N/A |
| 6/30/2019 | 399 | 115 | 30 | 120 | N/A |
| 3/31/2019 | 353 | 93 | 18 | 87 | N/A |
| 12/31/2018 | 292 | 68 | 17 | 65 | N/A |
| 9/30/2018 | 223 | 45 | -12 | 41 | N/A |
| 6/30/2018 | 153 | 27 | N/A | 30 | N/A |
| 3/31/2018 | 133 | 25 | N/A | 34 | N/A |
| 12/31/2017 | 121 | 19 | N/A | 20 | N/A |
| 9/30/2017 | 110 | 22 | N/A | 29 | N/A |
| 6/30/2017 | 102 | 21 | N/A | 30 | N/A |
| 3/31/2017 | 89 | 17 | N/A | 33 | N/A |
| 12/31/2016 | 89 | 14 | N/A | 23 | N/A |
| 9/30/2016 | 75 | 14 | N/A | 26 | N/A |
| 6/30/2016 | 61 | 10 | N/A | 15 | N/A |
| 3/31/2016 | 51 | 6 | N/A | 12 | N/A |
| 12/31/2015 | 40 | 2 | N/A | 9 | N/A |
| 1/1/2015 | 20 | 1 | N/A | 3 | N/A |
| 12/31/2013 | 19 | 0 | N/A | 4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 301206's forecast earnings growth (36.6% per year) is above the savings rate (2.9%).
Earnings vs Market: 301206's earnings (36.6% per year) are forecast to grow faster than the CN market (25% per year).
High Growth Earnings: 301206's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 301206's revenue (20.2% per year) is forecast to grow faster than the CN market (13.9% per year).
High Growth Revenue: 301206's revenue (20.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 301206's Return on Equity is forecast to be high in 3 years time